Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 3
2002 1
2003 1
2005 2
2007 1
2008 3
2009 4
2010 6
2011 2
2012 2
2013 4
2014 4
2015 7
2016 1
2017 4
2018 6
2019 5
2020 11
2021 9
2022 9
2023 11
2024 4
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, Schoch R, Gattermann N, Sanz G, List A, Gore SD, Seymour JF, Bennett JM, Byrd J, Backstrom J, Zimmerman L, McKenzie D, Beach C, Silverman LR; International Vidaza High-Risk MDS Survival Study Group. Fenaux P, et al. Lancet Oncol. 2009 Mar;10(3):223-32. doi: 10.1016/S1470-2045(09)70003-8. Epub 2009 Feb 21. Lancet Oncol. 2009. PMID: 19230772 Free PMC article. Clinical Trial.
Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort.
Lefèvre G, Bleuse S, Puyade M, Moulis G, Néel A, Abisror N, Baudet A, Bonnotte B, Dion J, Dossier A, Grall M, Lifermann F, Limal N, Lioger B, Machelart I, Mohr C, Outh R, Queyrel-Moranne V, Slama B, Tréfond L, Abou Chahla W, Ackerman F, Belfeki N, Berezne A, Blade JS, Bouderbala MA, Chebrek S, Cottin V, De Almeida S, De Masson A, Dezoteux F, Goulenok T, Jachiet V, Jouvray M, Latu I, Ledoult E, Leurs A, Lugosi M, Martin M, Melboucy-Belkhir S, Morati-Hafsaoui C, Quemeneur T, Rohmer J, Roy-Peaud F, Sanges S, Schleinitz N, Staumont-Salle D, Taillé C, Terriou L, Tieulie N, Koenga JDE, Schwarb L, Panel K, Kahn JE, Groh M; COHESion study group. Lefèvre G, et al. Allergy. 2025 Apr;80(4):1100-1110. doi: 10.1111/all.16463. Epub 2025 Jan 5. Allergy. 2025. PMID: 39757773
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.
Chevallier P, Leguay T, Delord M, Salek C, Kim R, Huguet F, Hicheri Y, Wartiovaara-Kautto U, Raffoux E, Cluzeau T, Balsat M, Roth-Guepin G, Tavernier E, Lepretre S, Bilger K, Bergugnat H, Berceanu A, Alexis M, Doubek M, Brissot E, Hunault-Berger M, Lebon D, Turlure P, Chantepie S, Belhabri A, Wickenhauser S, Bastie JN, Cacheux V, Himberlin C, Banos A, Gardin C, Bonnet S, Plantier I, Pica GM, Escoffre-Barbe M, Boissel N, Dombret H, Clappier E, Rousselot P; Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) and the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL); European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL). Chevallier P, et al. Among authors: hunault berger m. J Clin Oncol. 2024 Dec 20;42(36):4327-4341. doi: 10.1200/JCO.24.00490. Epub 2024 Oct 17. J Clin Oncol. 2024. PMID: 39418626 Clinical Trial.
Molecular relapse after first-line intensive therapy in patients with CBF or NPM1-mutated acute myeloid leukemia - a FILO study.
Orvain C, Bertoli S, Peterlin P, Desbrosses Y, Dumas PY, Iat A, Hospital MA, Carre M, Tavernier E, Riou J, Bouvier A, Bidet A, Tondeur S, Renosi F, Mozziconacci MJ, Flandrin-Gresta P, Dadone-Montaudié B, Delabesse E, Pigneux A, Hunault-Berger M, Recher C. Orvain C, et al. Among authors: hunault berger m. Leukemia. 2024 Sep;38(9):1949-1957. doi: 10.1038/s41375-024-02335-2. Epub 2024 Jul 17. Leukemia. 2024. PMID: 39020060 Free PMC article.
Comparison of induction with arsenic trioxide or chemotherapy in a real-world cohort of patients with high-risk acute promyelocytic leukemia.
Lebon D, Da Rocha A, Cassinat B, Heiblig M, Bertoli S, Bonmati C, Zilliox A, Laloi M, Berthon C, Duployez N, Willekens C, Hernanz MPG, Ochmann M, Cluzeau T, Chermat F, Caulier A, Récher C, Hunault-Berger M, Raffoux E, Fenaux P, Marolleau JP, Adès L. Lebon D, et al. Among authors: hunault berger m. Leukemia. 2025 Aug;39(8):1865-1870. doi: 10.1038/s41375-025-02663-x. Epub 2025 Jun 24. Leukemia. 2025. PMID: 40555732
Relationship between additional mutations at diagnosis and treatment response in patients with essential thrombocythemia.
Mosnier C, Bellal S, Cottin L, Boyer F, Lemoine S, Bachelot A, Argentin J, Pawlicki B, Copin MC, Jouanneau-Courville R, Malinge A, Riou J, Hunault-Berger M, Ugo V, Orvain C, Luque Paz D. Mosnier C, et al. Among authors: hunault berger m. Blood Adv. 2025 Mar 25;9(6):1303-1311. doi: 10.1182/bloodadvances.2024014791. Blood Adv. 2025. PMID: 39820709 Free PMC article.
Intensive therapies in follicular non-Hodgkin lymphomas.
Hunault-Berger M, Ifrah N, Solal-Celigny P; Groupe Ouest-Est des Leucémies Aiguëe et des Maladies du Sang. Hunault-Berger M, et al. Blood. 2002 Aug 15;100(4):1141-52. Blood. 2002. PMID: 12149190 Free article. Review. No abstract available.
WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis.
Cottin L, Riou J, Boyer F, Bouvier A, Zannetti A, Blouet A, Truchan-Graczyk M, Jouanneau-Courville R, Beucher A, Ribourtout B, Orvain C, Hunault-Berger M, Blanchet O, Ugo V, Luque Paz D. Cottin L, et al. Among authors: hunault berger m. Blood Cells Mol Dis. 2019 Mar;75:35-40. doi: 10.1016/j.bcmd.2018.12.004. Epub 2018 Dec 20. Blood Cells Mol Dis. 2019. PMID: 30612065 Free article.
89 results